Chemical Compound
Butanediamide, N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxy-, methanesulfonate (1:1); Deferoxamine mesilate; N'-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino]-4-oxobutanoyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide methanesulfonate; Butanediamide, N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate (salt); Propionohydroxamic acid, N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]-, methanesulfonate; Propionohydroxamic acid, N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]-, monomethanesulfonate (salt); Ba 33112; DFOM; DFX mesylate; Deferoxamine B mesylate; Deferoxamine mesylate; Deferoxamine methanesulfonate;
CAS Registry Number
138-14-7
Primary record
Butanediamide, N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxy-, methanesulfonate (1:1); Deferoxamine mesilate; N'-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino]-4-oxobutanoyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide methanesulfonate; Butanediamide, N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate (salt); Propionohydroxamic acid, N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]-, methanesulfonate; Propionohydroxamic acid, N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]-, monomethanesulfonate (salt); Ba 33112; DFOM; DFX mesylate; Deferoxamine B mesylate; Deferoxamine mesylate; Deferoxamine methanesulfonate;
- 库存
- 9,690 克
- 纯度
- 99.5 %
- CAS
- 138-14-7
化合物标识与属性
- CAS
- 138-14-7
- PubChem CID
- 62881
- SMILES
- CC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCNC(=O)CCC(=O)N(CCCCCN)O)O)O.CS(=O)(=O)O
- Canonical SMILES
- CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN.CS(=O)(=O)O
名称与同义词
- Deferoxamine mesylate
- Desferal
- Deferoxamine mesilate
- Desferal mesylate
- 138-14-7
- Desferrioxamine mesylate
- Desferrioxamine B mesylate
- deferoxamine
- DFOM
- Deferoxamine B mesylate
- Deferoxamine mesylate salt
- Deferoxamine methanesulfonate
- DFX mesylate
- Deferoxamine (mesylate)
- Deferoxamini mesilas
- deferoxaminemesylate
- Desferal methanesulfonate
- Desferal (TN)
- DESFERRIOXAMINE MESILATE
- Prestwick_988
- V9TKO7EO6K
- Desferrioxamine methanesulfonate
- Desferioxamine mesylate
- Mesilate, Deferoxamine
- Mesylate, Deferoxamine
- UNII-V9TKO7EO6K
- Deferoxamine mesylate [USAN]
- Deferoxamine Mesilate RS
- Deferoxamine-D8 mesylate
- AC1Q5IOG
- Desferrioxamine B methanesulfonate
- RefChem:585617
- Deferoxamine mesilate CRS
- DTXSID6037649
- D0FJ8A
- AC1L1XZ1
- Mesylate, Desferrioxamine B
- MLS000028713
- C26H52N6O11S
- CCRIS 8311
- CHEMBL1234
- Desferrioxamine mesylate salt
- Ba-33112
- Deferoxamine mesylate (USP)
- Desferrioxamine B mesylate;DFOM
- DTXCID4017649
- KSC959A0B
- Methanesulfonate, Deferoxamine
- NSC-756718
- SCHEMBL119982
- SPECTRUM1500224
- Deferoxamine mesilate (JP17)
- EINECS 205-314-3
- Ba 33122
- C25H48N6O8.CH4O3S
- IDDIJAWJANBQLJ-UHFFFAOYSA-N
- MFCD00058605
- Deferoxamine mesylate [USAN:USP]
- orb1307936
- Deferrioxamine B methanesulfonate
- CHEBI:31460
- CTK8F9000
- ERK5-1I18
- HMS500E04
- HY-B0988R
- Deferoxamine methanesulfonate salt
- NSC644468
- GLXC-07726
- HMS1570A12
- HMS1920C16
- HMS2091K08
- HMS2097A12
- HMS2234H23
- HMS3714A12
- HMS5085M21
- Pharmakon1600-01500224
- DEFEROXAMINE MESILATE [JAN]
- AKB-4924
- BCP31290
- CID62881
- Deferoxamine (mesylate) (Standard)
- EX-A4085
- HY-B0988
- Tox21_110741
- Ba 33112
- CCG-39770
- DEFEROXAMINE MESYLATE [VANDF]
- NCGC00017021-01
- NSC756718
- s5742
- CAS-138-14-7
- AKOS026750165
- DEFEROXAMINE MESILATE [WHO-DD]
- DEFEROXAMINE MESILATE [WHO-IP]
- DEFEROXAMINE MESYLATE [USP-RS]
- Tox21_110741_1
- CS-4479
- EBC-102073
- FD20885
- NSC 644468
- NSC 756718
- NSC-644468
- DESFERRIOXAMINE MESILATE [MART.]
- DESFERRIOXAMINE MESYLATE [WHO-IP]
- NCGC00017021-02
- NCGC00017021-03
- NCGC00094640-01
- NCGC00094640-02
- NCGC00178802-06
- AC-36517
- AN-43810
- BC667333
- Deferoxamine Mesylate - CAS 138-14-7
- DEFEROXAMINE METHANESULFONATE [MI]
- SMR000058548
- SY066727
- DEFEROXAMINE MESYLATE [ORANGE BOOK]
- AB0035971
- DB-042415
- DEFEROXAMINE MESILATE [EP MONOGRAPH]
- Deferoxamine mesylate salt, 97% - 1G 1g
- DEFEROXAMINI MESILAS [WHO-IP LATIN]
- LS-124966
- 138-14-7, 70-51-9 [deferoxamine]
- C25-H48-N6-O8.C-H4-O3-S
- DEFEROXAMINE MESYLATE [USP MONOGRAPH]
- FT-0603121
- NS00079182
- ST24046423
- Y0490
- D-0675
- D01186
- 138D147
- A807339
- SR-01000695424
- SR-01000695424-2
- SR-01000695424-3
- SR-01000695424-4
- Deferoxamine mesylate salt, powder, >=92.5% (TLC)
- I14-98954
- Q27114315
- Desferrioxamine B mesylate; DFOM;Desferrioxamine mesylate
- N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide;methanesulfonic acid
- N-(5-(3-((5-Aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)propionohydroxamic acid monomethanesulfonate (salt)
- Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate
- Deferoxamine mesylate salt, European Pharmacopoeia (EP) Reference Standard
- Deferoxamine mesylate, United States Pharmacopeia (USP) Reference Standard
- N1-(5-aminopentyl)-N1-hydroxy-N4-(5-(N-hydroxy-4-((5-(N-hydroxyacetamido)pentyl)amino)-4-oxobutanamido)pentyl)succinamide methanesulfonate
- Propionohydroxamic acid, N-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propionamido)pentyl)-3-((5-(N-hydroxyacetamido)pentyl)carbamoyl)-, monomethanesulfonate (salt)
- Deferoxamine for system suitability, European Pharmacopoeia (EP) Reference Standard
- (Z)-4-((5-aminopentyl)(hydroxy)amino)-N-(5-((Z)-N,4-dihydroxy-4-((5-(N-hydroxyacetamido)pentyl)imino)butanamido)pentyl)-4-oxobutanimidic acid compound with methanesulfonic acid (1:1)
- 205-314-3
- BUTANEDIAMIDE, N'(-(((((ACETYLHYDROXYAMINO)PENTYL)MINO)1,4-DIOXOBUTYL)YDROXYAMINO)ENTYL)N-(5-AMINOPENTYL)-N-HYDROXY-, MONOMETHANESULFONATE
- BUTANEDIAMIDE, N'(-(((((ACETYLHYDROXYAMINO)PENTYL)MINO)1,4-DIOXOBUTYL)YDROXYAMINO)ENTYL)N-(5-AMINOPENTYL)-N-HYDROXY-, MONOMETHANESULPHONATE
- Butanediamide, N'-(5-((4-((5-(acetylhydroxyamino)pentyl)amino)-1,4-dioxobutyl)hydroxyamino)pentyl)-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate (salt)
- Butanediamide, N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate (salt)
- Butanediamide, N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxy-, methanesulfonate (1:1)
- Butanediamide, N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxy-, methanesulfonate (1:1); Deferoxamine mesilate; N'-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino]-4-oxobutanoyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxybutanediamide methanesulfonate; Butanediamide, N'-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]-N-(5-aminopentyl)-N-hydroxy-, monomethanesulfonate (salt); Propionohydroxamic acid, N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]-, methanesulfonate; Propionohydroxamic acid, N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]-, monomethanesulfonate (salt); Ba 33112; DFOM; DFX mesylate; Deferoxamine B mesylate; Deferoxamine mesylate; Deferoxamine methanesulfonate;
- Butanodiamida, N4-[5-[[4-[[5-(acetilhidroxiamino)pentil]amino]-1,4-dioxobutil]hidroxiamino] pentil]-N1-(5-aminopentil)-N1-hidroxi-, metanosulfonato (1:1)
- Methanesulfonic acid--N~1~-(5-aminopentyl)-N~1~-hydroxy-N~4~-[5-(N-hydroxy-4-{[5-(N-hydroxyacetamido)pentyl]amino}-4-oxobutanamido)pentyl]butanediamide (1/1)
- N'-(5-azanylpentyl)-N-[5-[[4-[5-[ethanoyl(oxidanyl)amino]pentylamino]-4-oxidanylidene-butanoyl]-oxidanyl-amino]pentyl]-N'-oxidanyl-butanediamide; methanesulfonic acid
- n'-{5-[acetyl(hydroxy)amino]pentyl}-n-[5-({4-[(5-aminopentyl)(hydroxy)amino]-4-oxobutanoyl}amino)pentyl]-n-hydroxysuccinamide methanesulfonate(1:1)
- N-(5-(3-((5-AMINOPENTYL)HYDROXYCARBAMOYL)PROPIONAMIDO)PENTYL)-3-((5-(N-HYDROXYACETAMIDO)PENTYL)CARBAMOYL)PROPIONOHYDROXAMIC ACID MONOMETHANESULPHONATE (SALT)
- N-(5-(Acetylhydroxyamino)pentyl)-N'-(5-(3-((5-aminopentyl)hydroxycarbamoyl)propanoylamino)pentyl)-N'-hydroxysuccinamide monomethanesulfonate
- N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-1,4-dioxobutyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide; methanesulfonic acid
- N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxo-butanoyl]-hydroxy-amino]pentyl]-N'-(5-aminopentyl)-N'-hydroxy-butanediamide;methanesulfonic acid
- N-[5-[[4-[5-[acetyl(hydroxy)amino]pentylamino]-4-oxobutanoyl]-hydroxyamino]pentyl]-N'-(5-aminopentyl)-N'-hydroxybutanediamide; methanesulfonic acid
- N-[5-[3-[(5-aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic Acid Methanesulfonate
- N-[5-[3-[(5-Aminopentyl)hydroxycarbamoyl]propionamido]pentyl]-3-[[5-(N-hydroxyacetamido)pentyl]carbamoyl]propionohydroxamic acid monomethanesulfonate (salt)
- N1-(5-(4-((5-Aminopentyl)amino)-4-oxobutanamido)pentyl)-N1-hydroxy-N4-(5-(N-hydroxyacetamido)pentyl)succinamide methanesulfonate
- N1-(5-aminopentyl)-N1-hydroxy-N4-[5-[[4-[[5-(acetylhydroxyamino)pentyl]amino]-1,4-dioxobutyl]hydroxyamino]pentyl]butanediamide Methanesulfonate
- N4-[5-[[4-[[5-(Acetylhydroxyamino)pentyl]amino-1,4-dioxobutyl]hydroxyamino]pentyl]-N1-(5-aminopentyl)-N1-hydroxybutanediamide methanesulfonate